SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-036412
Filing Date
2010-02-22
Accepted
2010-02-22 16:34:27
Documents
2
Period of Report
2010-02-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15311
2 SECOND AMENDED AND RESTATED BYLAWS dex32.htm EX-3.2 99655
  Complete submission text file 0001193125-10-036412.txt   116525
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 10623085
SIC: 2834 Pharmaceutical Preparations